Zymergen Inc.

SEC Charges Zymergen Inc. With Misleading IPO Investors About Company's Market Potential and Sales Prospects

Ginkgo Bioworks Completes Acquisition of Zymergen

ZYMERGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zymergen - ZY

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY

SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates GMTX, MANT, ZY, LOTZ

Investor Alert - The M&A Class Action Firm Announces the Investigation of Zymergen Inc. - ZY

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates IEA, ZY, FLAC

SHAREHOLDER ALERT: Weiss Law Investigates Infrastructure and Zymergen Inc.

Why Ginkgo Bioworks (DNA) Is Buying Zymergen For $300 Million

Shareholder Alert: Ademi LLP investigates whether Zymergen Inc. has obtained a Fair Price in its transaction with Ginkgo

Ginkgo Buys Embattled Biotech Firm Zymergen For Paltry $300 Million

Gingko Buys Embattled Biotech Firm Zymergen For Paltry $300 Million

ZY Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Zymergen Inc. Is Fair to Shareholders

Ginkgo to Acquire Zymergen

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications

Good Penny Stocks to Buy Now? 3 to Watch in June

Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

Zymergen: A Humbled Company With A Business On The Ropes

Zymergen, Inc. (ZY) CEO Jay Flatley on Q1 2022 Results - Earnings Call Transcript